Budesonide Suspension
Product Images NDC 60687-889

Product Visual Gallery

This gallery contains 9 technical images submitted to the FDA as part of the official labeling for Budesonide (NDC 60687-889). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by American Health Packaging, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

0.25 mg 2 mL Budesonide Inhalation Suspension Carton.jpg (0.25 mg 2 mL Budesonide Inhalation Suspension Carton.jpg)

Budesonide 0.25 mg/2 mL inhalation suspension labels from American Health Packaging. The labels include instructions for use, dosage strength, packaging information for 30 x 2 mL unit-dose ampules, and storage directions. The product is for respiratory inhalation only, labeled Rx only with NDC 60687-889.*

FDA Label Image

0.25 mg 2 mL Budesonide Inhalation Suspension Foil Pouch.jpg (0.25 mg 2 mL Budesonide Inhalation Suspension Foil Pouch.jpg)

Label for Budesonide Inhalation Suspension 0.25 mg/2 mL by American Health Packaging. The label details inhalation route usage, storage instructions at 20° to 25°C (68° to 77°F) with permitted excursions, and cautions against ultrasonic nebulizers. It includes dosage directions, packaging in a unit-dose ampule pouch, and a single unit-dose ampule per pouch.*

FDA Label Image

Spl-budesonide-fig-1 (Spl Budesonide Fig 1)

A line graph titled 'Nighttime Asthma Change from Baseline' showing mean change in nighttime asthma symptoms over a 12-week trial in pediatric patients. The graph compares placebo and three doses of Budesonide (0.25 mg, 0.5 mg, and 1 mg once daily) at intervals from baseline to 12 weeks, illustrating symptom changes over time.*

FDA Label Image

Spl-budesonide-fig-2 (Spl Budesonide Fig 2)

A line graph titled 'Nighttime Asthma Change from Baseline' from a 12-week pediatric trial comparing placebo, 0.25 mg twice daily, and 0.5 mg twice daily inhaled Budesonide. The graph shows mean changes from baseline in nighttime asthma symptoms over multiple 2-week intervals, with separate lines and markers for each treatment group. P-values for 0.25 mg and 0.5 mg doses versus placebo are noted below.*

FDA Label Image

Spl-budesonide-fig-3 (Spl Budesonide Fig 3)

A line graph illustrating nighttime asthma symptom changes over a 12-week trial in pediatric patients, comparing placebo and various dosing regimens of Budesonide (0.25 mg once daily, 0.25 mg twice daily, 0.5 mg twice daily) and another 0.5 mg twice daily treatment, with mean change from baseline on the y-axis and time intervals on the x-axis.*

FDA Label Image

Spl-budesonide-fig-5 (Spl Budesonide Fig 5)

Illustration showing a hand holding a single-use sterile oral inhalation suspension vial with a peel-off top. The vial label indicates it is sterile and intended for oral inhalation only. There is a large arrow curving around the vial, demonstrating the direction to open the cap.*

FDA Label Image

Spl-budesonide-fig-6 (Spl Budesonide Fig 6)

An instructional illustration showing two hands opening a Budesonide respiratory suspension unit-dose container by twisting off the top cap. The label on the container is partially visible and includes the text 'For oral inhalation only.' An arrow indicates the direction to twist the cap to open.*

FDA Label Image

Spl-budesonide-fig-7 (Spl Budesonide Fig 7)

An instructional line drawing showing two hands using a unit-dose ampule labeled 'STERILE For oral inhalation only.' Liquid from the ampule is being poured into a small respiratory nebulizer cup, held by the other hand. The illustration demonstrates the preparation of a respiratory suspension for inhalation.*

FDA Label Image

Spl-budesonide-str (Spl Budesonide Str)

Chemical structure of budesonide, a corticosteroid active ingredient used in respiratory inhalation suspensions.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.